Amgen (AMGN)

R&D Expense Growth

8.67%

Quarterly · Period ending:

AMGN logo

AMGN R&D Expense Growth

Latest reported8.67%
AMGN Quarterly R&D Growth (QoQ) (0.00% → 8.67%)
High-resolution chart · PNG

AMGN r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Amgen R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
1.016%
-17.1543%
22.967%
0.0493%
6.8493%
-21.6674%
22.127%
2.2154%
3.2447%
-2.2869%
15.9036%
8.9239%
-0.0656%
-7.6317%
-4.3453%
18.707%
-1.5572%
2.7836%
10.1994%
5.5016%
-5.3599%
5.3226%
17.5355%
-2.6753%
-4.8288%
29.4318%
7.8431%
1.7456%
8.8195%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.